These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 30012195

  • 1. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
    Wang S, Zhang Y, Mensah V, Huber WJ, Huang YT, Alvero R.
    J Ovarian Res; 2018 Jul 16; 11(1):60. PubMed ID: 30012195
    [Abstract] [Full Text] [Related]

  • 2. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
    Sadruddin S, Barnett B, Ku L, Havemann D, Mucowski S, Herrington R, Burggren W.
    PLoS One; 2020 Jul 16; 15(10):e0239779. PubMed ID: 33044971
    [Abstract] [Full Text] [Related]

  • 3. Age effect on in vitro fertilization pregnancy mediated by anti-Mullerian hormone (AMH) and modified by follicle stimulating hormone (FSH).
    Hsieh HC, Su JY, Wang S, Huang YT.
    BMC Pregnancy Childbirth; 2020 Apr 09; 20(1):209. PubMed ID: 32272911
    [Abstract] [Full Text] [Related]

  • 4. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.
    Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O, Oktem M.
    J Assist Reprod Genet; 2013 Jun 09; 30(5):657-65. PubMed ID: 23508679
    [Abstract] [Full Text] [Related]

  • 5. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
    Grzegorczyk-Martin V, Khrouf M, Bringer-Deutsch S, Mayenga JM, Kulski O, Cohen-Bacrie P, Benaim JL, Belaisch-Allart J.
    Gynecol Obstet Fertil; 2012 Jun 09; 40(7-8):411-8. PubMed ID: 22521986
    [Abstract] [Full Text] [Related]

  • 6. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
    Lukaszuk K, Liss J, Kunicki M, Jakiel G, Wasniewski T, Woclawek-Potocka I, Pastuszek E.
    Reprod Biol; 2014 Sep 09; 14(3):176-81. PubMed ID: 25152514
    [Abstract] [Full Text] [Related]

  • 7. Low antimüllerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle-stimulating hormone and AMH are discordant.
    Ligon S, Lustik M, Levy G, Pier B.
    Fertil Steril; 2019 Jul 09; 112(1):73-81.e1. PubMed ID: 31056310
    [Abstract] [Full Text] [Related]

  • 8. How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields.
    Gleicher N, Darmon SK, Kushnir VA, Weghofer A, Wang Q, Zhang L, Albertini DF, Barad DH.
    Endocrine; 2016 Nov 09; 54(2):476-483. PubMed ID: 27510172
    [Abstract] [Full Text] [Related]

  • 9. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov 09; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 10. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
    Leader B, Hegde A, Baca Q, Stone K, Lannon B, Seifer DB, Broekmans F, Baker VL.
    Fertil Steril; 2012 Oct 09; 98(4):1037-42. PubMed ID: 22771028
    [Abstract] [Full Text] [Related]

  • 11. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y, Kim TH, Park JK, Eum JH, Lee HJ, Kim J, Lyu SW, Kim YS, Lee WS, Yoon TK.
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb 09; 221():151-155. PubMed ID: 29306180
    [Abstract] [Full Text] [Related]

  • 12. Retrospective study of ovarian reaction and fertility in women with discordant antimullerian hormone and follicle-stimulating hormone/luteinizing hormone ratios during in vitro fertilization.
    Wang J, Lv Y, Wang X, Zhu G, Zhao F.
    J Obstet Gynaecol Res; 2023 Mar 09; 49(3):966-972. PubMed ID: 36734373
    [Abstract] [Full Text] [Related]

  • 13. Discordance between day-3 follicle stimulating hormone & anti-Müllerian hormone is predictive of clinical pregnancy during fertility treatment.
    Butler WJ, Pico A, Hawkins KC, Younis AI.
    Gynecol Endocrinol; 2021 Sep 09; 37(9):798-801. PubMed ID: 33355011
    [Abstract] [Full Text] [Related]

  • 14. Basal Serum Anti-Müllerian Hormone Level as a Predictor of Clinical Outcomes in Freezing-all Embryo Transfer Program.
    Li XL, Huang R, Fang C, Liang XY.
    Curr Med Sci; 2018 Oct 09; 38(5):861-867. PubMed ID: 30341521
    [Abstract] [Full Text] [Related]

  • 15. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å, Nilsson L, Oleröd G, Thurin-Kjellberg A, Bergh C.
    Hum Reprod; 2017 Apr 01; 32(4):811-819. PubMed ID: 28175316
    [Abstract] [Full Text] [Related]

  • 16. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
    Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun 01; 168(2):173-7. PubMed ID: 23485092
    [Abstract] [Full Text] [Related]

  • 17. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy.
    Nelson SM, Yates RW, Fleming R.
    Hum Reprod; 2007 Sep 01; 22(9):2414-21. PubMed ID: 17636277
    [Abstract] [Full Text] [Related]

  • 18. Comparing four ovarian reserve markers--associations with ovarian response and live births after assisted reproduction.
    Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J.
    Acta Obstet Gynecol Scand; 2015 Oct 01; 94(10):1056-63. PubMed ID: 26184379
    [Abstract] [Full Text] [Related]

  • 19. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH.
    Gleicher N, Kushnir VA, Sen A, Darmon SK, Weghofer A, Wu YG, Wang Q, Zhang L, Albertini DF, Barad DH.
    J Transl Med; 2016 Jun 10; 14(1):172. PubMed ID: 27286817
    [Abstract] [Full Text] [Related]

  • 20. Anti-müllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-müllerian hormone is modest.
    Alson SSE, Bungum LJ, Giwercman A, Henic E.
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun 10; 225():199-204. PubMed ID: 29738982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.